PATENT CLAIM ANALYSIS

Application Number: 16210495
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["514", "267000"]

Abstract:
Disclosed herein are tricyclic compounds, including thieno[2,3-d:4,5-d′]dipyrimidin-4-amine and pyrido[4′,3′:4,5]thieno[2,3-d]pyrimidin-8-amine compounds, which may be useful as positive allosteric modulators of the muscarinic acetylcholine receptor M 4  (mAChR M 4 ). Also disclosed herein are methods of making the compounds, pharmaceutical compositions comprising the compounds, and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.

Claim (Index 9):
The compound of  claim 1 , or a pharmaceutically acceptable salt thereof, wherein\n R 2  is hydrogen or C 1 -C 4  alkyl; and R 3  is selected from alkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, heteroalkyl, heterocycle, and \u2014(CR e R f ) n \u2014Y.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 98.0
- Lexical Diversity: 1.58824
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15630200', '15661786', '15703451', '14345244', '13735017']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8184130013001036
- 35 USC 102 Novelty (BERT): 0.5948026628288405
- Combined Prediction Score: 0.7960519674529773
- Mean Citation Score: 435.446984
- Max Citation Score: 528.5691
- Similarity Product: 450.746595815456

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test